ASML Q3 2026: Record Profit, Orders to 2030, Shares Slip

ASML, the Dutch maker of the machines used to print advanced chips, reported record third-quarter sales of €11.7 billion on October 14 and said some customers are already discussing orders for 2029 and 2030. Its shares still slipped: the New York-listed shares closed down 1.86% on the day. The stock had already risen about 56% this year, so a very good report was largely expected, and the market looked for what could go wrong.

Key takeaways

• Q3 net sales were €11.7B, net income €5.0B and gross margin 57.5%, all records. Q4 sales are guided to €14.2–15.2B.
• Part of the profit beat is a one-off: net income includes a €500M gain on ASML's investment in French AI company Mistral.
• ASML says planned 2027 and 2028 supply won't meet customer demand, and it is looking at expanding beyond its earlier plan of 30% more capacity.

What did ASML report?

Full-year 2026 sales are now guided at €44 billion to €45 billion, with a gross margin around 56%. That raises the low end from €43 billion, and it compares with the €36–40 billion range ASML guided before its July increase. Installed-base sales, meaning service and upgrades on machines already in the field, reached €3.3 billion, above guidance. ASML also bought back about €4.1 billion of its shares in the quarter.

Did profit really smash expectations?

Yes, but read the detail. Analysts had expected net income of about €4.1 billion, against the €4.96 billion reported. About €500 million of that comes from revaluing ASML's first tranche of investment in Mistral, so the underlying beat is smaller, around €4.5 billion before that gain, still above forecasts.

Sales themselves were roughly in line with the €11.7 billion consensus. The cleanest beat was margin: 57.5% against a guided 55–57% and about 55.9% expected by analysts, helped by the strong mix of upgrade revenue. That is why the headline "smashes expectations" is fair on profit, but not on sales.

What does "demand through 2030" actually mean?

CEO Christophe Fouquet said customers keep raising their equipment forecasts, "driven primarily by their views on the size and duration of AI-related investments." Some, he said, have started to express interest in placing orders for 2029 and even 2030. He added that customers already expect supply not to meet demand until at least 2028.

Two cautions. First, interest is not signed orders, and nothing in this report puts a number on it. Second, demand outrunning supply is a good problem, but it has a cost: ASML said the 30% capacity increase planned for 2027 and another 30% in 2028 will not be enough, and it is investigating ways to expand beyond that. Capacity is built with long lead times, so promises about 2029 depend on suppliers, factories and customers' own financing holding up.

For scale, management said it expects to ship about 65 of its EUV machines this year, more than 50% above last year, according to Investing.com's summary of its slides. JPMorgan notes that most orders for ASML's advanced tools are already scheduled for 2028 delivery, per Benzinga.

Why did the shares slip?

Expectations were high and the backdrop was nervous. ASML's New York shares closed at $1,717.76, down 1.86%, then fell another 2.26% after hours to $1,679. Before the report the stock was about 9.5% below its June high, and chip shares had already been sold this week.

The sector's mood is not hard to explain. On October 13, the IMF's financial stability report named an AI-related market correction among its top risks, and South Korea's Kospi fell 5.5% on AI-share selling, as we covered in the IMF's warning about an AI-related market correction. When a stock has gained so much, even a strong quarter can fall short, the same mechanism we described in why prices can fall even when earnings look strong.

What are the risks?

• AI financing. ASML's order book depends on customers' appetite to spend on AI capacity. The IMF pointed to three sources of borrowing behind the boom: debt raised by AI companies, hedge funds' positions and retail margin buying. If financing tightens, orders could slow.
• China. ASML says China will remain about 20% of sales, as previously forecast. Export restrictions on EUV and some DUV tools limit that business and could tighten.
• Execution. Doubling capacity quickly means long-lead components and trained staff. Delays would push revenue out.
• Concentration. A few large customers drive demand. If one cuts spending, the effect is large.
• AI risk itself. As our coverage of OpenAI's training pauses and rogue agents showed, regulators are paying closer attention to AI, which can slow deployment.

What to watch next

1. Q4 delivery. Guidance of €14.2–15.2 billion means sales rising 22% to 30% from Q3. Missing the low end would matter.
2. A capacity decision. Any formal plan to expand beyond the +30% in 2027 and 2028.
3. Order evidence. Whether "interest" for 2029–2030 turns into firm orders.
4. China and export rules. Any change in US or Dutch restrictions.
5. The AI credit picture. Funding conditions for ASML's largest customers.

The Constraint Is Supply, and the Risk Is the Customers

The usual worry about a chip equipment maker is weak demand. ASML's problem is the reverse: it cannot build fast enough, which is why margins are rising and customers are booking years ahead. That makes the near-term numbers look secure. What the market is pricing is what lies behind them: whether the AI spending that drives those orders continues at this pace, and whether it can be financed. ASML controls its own capacity. It doesn't control its customers' balance sheets.

FAQ

What were ASML's Q3 2026 results? Net sales of €11.7 billion, net income of €5.0 billion and a gross margin of 57.5%, all company records. Net income includes a €500 million gain on its Mistral investment.

Why did ASML shares fall after a record quarter? Expectations were high after a 56% rise this year, sales were only in line, and chip stocks were already under pressure from fears about AI spending. The shares fell 1.86% in New York.

What is ASML's outlook? Q4 sales of €14.2–15.2 billion and full-year 2026 sales of €44–45 billion, with a gross margin around 56%. Management says 2027 and 2028 supply will not fully meet demand.

Sources: ASML Q3 2026 press release and earnings call (October 14, 2026), CNBC, Reuters, Investing.com, Benzinga, Silicon Republic, NL Times. Share-price data as of October 14, 2026. This article is for informational purposes only and does not constitute investment advice.